15 results
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
, in collaboration with Brooke Army Medical Center in San Antonio, Texas, and partially funded by the DOD.
Chronic Obstructive Pulmonary Disease
POS AM
BIAF
BioAffinity Technologies Inc
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
by the DOD.
Chronic Obstructive Pulmonary Disease and Other Diseases of the Lung.
The respiratory diagnostics market was valued at $5.6 billion in 2023
DRS
exmdtdzyl0x9
14 Aug 23
Draft registration statement
12:00am
8-K
EX-99.1
a78tr7z64
31 Mar 23
Results of Operations and Financial Condition
7:12pm
10-K
zckrhp9ca26 1b5banu
31 Mar 23
Annual report
3:40pm
424B4
zxfwqm62b6fmh2
2 Sep 22
Prospectus supplement with pricing info
3:25pm
S-1
a7oln7udr pw
25 Apr 22
IPO registration
6:16am
- Prev
- 1
- Next